stars 1 stars 2 stars 3

At DaltonTx, we are redefining how technology powers drug discovery — creating the intelligence engine behind tomorrow’s medicines. Our adaptive, AI-enabled platforms give pharma, biotech, and CROs the intelligence backbone modern R&D cannot move forward without. Purpose-built for small molecules and biologics, our technology integrates seamlessly into scientific workflows, learns from every experiment, and accelerates the path from idea to medicine. Unlike traditional project-based models, DaltonTx provides lasting capability: collaborative systems that combine machine learning, software engineering, and deep drug discovery expertise. The result is technology that learns from every scientist, model, and experiment — guiding better decisions, evolving with your science, and helping you deliver breakthrough therapies to patients faster. Founded by scientists for scientists, DaltonTx brings together decades of real-world experience in drug discovery, software engineering, and AI. The team — Dr Garry Pairaudeau, Adrian Rossall, Dr Anthony Bradley, and Professor Charlotte Deane MBE — has built pioneering AI discovery platforms at AstraZeneca and Exscientia, while also drawing on world-leading academic research from the University of Oxford. This unique combination of industry execution and academic excellence positions DaltonTx at the forefront of AI-enabled drug discovery.

Website https://daltontx.com
Employees 24 (13 on RocketReach)
Industry Biotechnology Research

Dalton Questions

Garry Pairaudeau is the CEO and Cofounder of Dalton.

13 people are employed at Dalton.

Dalton is based in London, England.

Top Dalton Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users